# NYSTATIN
> **ANDA219527** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2025-03-21
## Drug
- **FDA Application Number:** ANDA219527
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN
- **Generic name:** NYSTATIN
- **Active ingredients:** NYSTATIN
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2025-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219527)
---
*MORVS · CC0 1.0*